Design Therapeutics, Inc (DSGN) insider trading

Every open-market stock purchase and sale by Design Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: John P. Schmid (Insider), $66.6K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $10.53 on Jun 11, 2026.

Recent DSGN insider trades

DateInsiderTradeValue
Jun 9, 2026Simeon George (Insider)Bought (not open market)—
Jun 9, 2026Heather A. Berger (Insider)Bought (not open market)—
Jun 9, 2026Rodney W Lappe (Insider)Bought (not open market)—
Jun 9, 2026Justin D. Gover (Insider)Bought (not open market)—
Jun 9, 2026David Shapiro (Insider)Bought (not open market)—
Jun 9, 2026John P. Schmid (Insider)Bought (not open market)—
Mar 31, 2026David Shapiro (Insider)Bought (not open market)—
Mar 31, 2026David Shapiro (Insider)Bought (not open market)—
Jan 2, 2026Sean Jeffries (COO)Bought (not open market)—
Jan 2, 2026Chris Storgard (C-suite exec)Bought (not open market)—
Jan 2, 2026Pratik Shah (CEO)Bought (not open market)—
Jan 2, 2026Justin D. Gover (Insider)Bought (not open market)—
Jan 2, 2026Julie Burgess (C-suite exec)Bought (not open market)—
Dec 9, 2025Pratik Shah (CEO)Bought (not open market)—

Who's trading DSGN

Get free alerts when an insider at Design Therapeutics, Inc files a new trade →